Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A could downregulate GPR62 by inhibiting histone deacetylase activity, which would result in a more closed chromatin configuration at the GPR62 gene promoter, leading to decreased transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor may disrupt the methylation pattern on the DNA where the GPR62 gene resides, resulting in reduced binding of methyl-CpG-binding domain proteins and a subsequent decrease in GPR62 transcription. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG 108 might decrease GPR62 expression by specifically preventing the methylation of cytosine residues within the promoter region of the GPR62 gene, thereby removing repressive epigenetic marks that suppress gene transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid may lead to the downregulation of GPR62 through the inhibition of class I and II histone deacetylases, which would enhance acetylation of histones near the GPR62 gene, paradoxically causing repression of transcription in some contexts. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
MS-275 could decrease GPR62 expression by selectively inhibiting class I histone deacetylases, promoting a compact chromatin structure around the GPR62 promoter and reducing the accessibility for transcriptional machinery. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
By incorporating into DNA and trapping DNA methyltransferases, 5-Aza-2′-Deoxycytidine could lead to a reduction in GPR62 expression due to a failure to maintain methylation patterns at the GPR62 gene promoter during DNA replication. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
Romidepsin may inhibit GPR62 expression by selectively targeting class I histone deacetylases, resulting in the accumulation of acetylated histones that are associated with silenced genes, including potentially the GPR62 gene. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Panobinostat could broadly decrease GPR62 expression by inhibiting a wide range of histone deacetylases, leading to altered acetylation patterns on histones associated with the GPR62 gene, which could repress its transcription. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $182.00 $661.00 | 10 | |
Chetomin could attenuate GPR62 expression by disrupting the function of hypoxia-inducible factors that may be involved in the upregulation of GPR62 under hypoxic conditions, thus leading to a decreased expression level. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin may inhibit GPR62 expression by blocking the mTOR pathway, which is involved in the control of cell growth and protein synthesis; this blockade could lead to a general decrease in the transcription of certain genes, possibly including GPR62. | ||||||